Skip to main content
. 2021 Jan 8;10:598603. doi: 10.3389/fonc.2020.598603

Figure 1.

Figure 1

The ROC curves for the relative risk model in discriminating ESCC patients from healthy controls. (A) ROC curve without cross-validation (B) ROC curve with 10-fold cross-validation (C) ROC curve with leave-one-out cross-validation, The optimal cut-off points (dots) were marked on the ROC curves. ESCC, esophageal squamous cell carcinoma. ROC, receiver-operating characteristic curve.